Systemic amyloidosis of beta 2-microglobulin type: a complication of long-term haemodialysis.
- 1 October 1987
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 40 (10) , 1247-1251
- https://doi.org/10.1136/jcp.40.10.1247
Abstract
A patient receiving long-term haemodialysis developed systemic amyloidosis, which was shown immunohistochemically to be of beta 2-microglobulin type, a previously unrecognised form of systemic amyloidosis. Histologically, the amyloid deposits were closely associated with foci of acute and granulomatous inflammation and vasculitis, although it was not clear if the amyloid deposits directly caused the inflammatory process, or if amyloid was deposited preferentially in areas of inflammation of uncertain aetiology.Keywords
This publication has 16 references indexed in Scilit:
- Dialysis arthropathy: amyloid or iron?BMJ, 1986
- Acquired cystic disease of the kidney: serious or irrelevant?BMJ, 1986
- β2-MICROGLOBULIN-ASSOCIATED AMYLOIDOSIS IN CHRONIC HAEMODIALYSIS PATIENTSThe Lancet, 1986
- HAEMODIALYSIS VERSUS CAPD: EQUAL PREDISPOSITION TO AMYLOIDOSIS?The Lancet, 1986
- Serum Levels of β2-Microglobulin as a New Form of Amyloid Protein in Patients Undergoing Long-Term HemodialysisNew England Journal of Medicine, 1986
- Beta-2 microglobulin is an amyloidogenic protein in man.Journal of Clinical Investigation, 1985
- A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulinBiochemical and Biophysical Research Communications, 1985
- Hepatic copper distribution in primary biliary cirrhosis shown by the scanning proton microprobe.Journal of Clinical Pathology, 1985
- Peripheral Nerve Entrapment Syndromes in Chronic Hemodialysis PatientsNephron, 1982
- Amyloid Deposits and AmyloidosisNew England Journal of Medicine, 1980